Join the Spinraza group to help and get support from people like you.
Spinraza News
What You Should Know About Spinal Muscular Atrophy (SMA)
MONDAY, Aug. 11, 2025 — Spinal muscular atrophy (SMA) is a genetic neuromuscular disease affecting specialized nerve cells that control voluntary muscle movement, according to the Muscular Dystrophy A...
FDA Approves Spinraza (nusinersen) for Spinal Muscular Atrophy
December 23, 2016 – The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and...